EPITHELIOID SARCOMA
Clinical trials for EPITHELIOID SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID SARCOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell combo aims to fight stubborn childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid. The goal is to help the donor cells attack the tumor without causing severe side effects. It is for children and young adults a…
Matched conditions: EPITHELIOID SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 00:31 UTC
-
Last-resort drug offered to patients with rare, aggressive cancers
Disease control AVAILABLEThis program provides early access to ubamatamab, an experimental drug, for people with two rare and serious cancers: renal medullary carcinoma and epithelioid sarcoma. The goal is to offer a potential treatment option when no other therapies are available. Eligibility is decided…
Matched conditions: EPITHELIOID SARCOMA
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New oral drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called HH2853 for people with certain types of blood cancer (non-Hodgkin's lymphoma) or advanced solid tumors that have come back or not responded to treatment. The goal is to find the safest dose and see if the drug can shrink tumors. About …
Matched conditions: EPITHELIOID SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC
-
Scientists dive deep into rare sarcomas to unlock immune secrets
Knowledge-focused Recruiting nowThis study aims to learn more about the immune system's role in rare soft tissue sarcomas. Researchers will collect and analyze blood and tumor samples from 400 patients with these uncommon cancers. The goal is to find patterns that could help predict how the disease will progres…
Matched conditions: EPITHELIOID SARCOMA
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
Scientists watch and learn: new study tracks rare sarcoma patients
Knowledge-focused Recruiting nowThis study is for 100 people with epithelioid sarcoma, a rare type of cancer. Researchers will watch how patients are treated (with chemotherapy, radiation, or other methods) and look for markers in tumor tissue that might predict how well treatments work. No new treatments are g…
Matched conditions: EPITHELIOID SARCOMA
Sponsor: Italian Sarcoma Group • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC